UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000048357
Receipt No. R000053953
Scientific Title Analysis of factors associated with Crohn's Disease activity and evaluation of the efficacy of improving sleep disturbances on maintenance of remission
Date of disclosure of the study information 2022/07/15
Last modified on 2022/07/12 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Analysis of factors associated with Crohn's Disease activity and evaluation of the efficacy of improving sleep disturbances on maintenance of remission
Acronym Association between Crohn's disease activity and sleep status
Scientific Title Analysis of factors associated with Crohn's Disease activity and evaluation of the efficacy of improving sleep disturbances on maintenance of remission
Scientific Title:Acronym Association between Crohn's disease activity and sleep status
Region
Japan

Condition
Condition Crohn's disease
Classification by specialty
Gastroenterology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Assess Crohn's disease activity and clarify its relationship to sleep status, stress, and quality of life, with objective indicators. Furthermore, we will provide patient guidance to improve sleep disturbance and investigate whether it is effective in maintaining remission.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Association between disease activity and sleep status in Crohn's disease.
Key secondary outcomes (1) Relationship between disease activity and stress in Crohn's disease
(2) Relationship between disease activity and quality of life in Crohn's disease
(3) Changes in sleep status after sleep guidance
(4) Changes in disease activity after sleep guidance

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification NO
Dynamic allocation NO
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Educational,Counseling,Training
Type of intervention
Behavior,custom
Interventions/Control_1 Only one in-person sleep improvement instruction session (approximately 15 minutes).
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with Crohn's disease aged 18 years or older who are regular visitors to Fukuoka University Hospital
Key exclusion criteria Patients with the following conditions are excluded: 1. psychiatric disorders, 2. sleep-related diseases such as severe insomnia and sleep apnea syndrome, 3. severe cardiac, liver, or renal diseases, 4. dementia, and 5. scheduled for surgery such as bowel resection or after surgery within 3 months, 6. difficult to answer the questionnaire, 7. otherwise judged as inappropriate by the physician in charge.
Target sample size 120

Research contact person
Name of lead principal investigator
1st name Fumihito
Middle name
Last name Hirai
Organization Fukuoka University Faculty of Medicine
Division name Department of Gastroenterology and Medicine
Zip code 8180180
Address 7-45-1, Nanakuma, Jonan-ku, Fukuoka city, Fukuoka
TEL 0928011011
Email fuhirai@cis.fukuoka-u.ac.jp

Public contact
Name of contact person
1st name Ashizuka
Middle name
Last name Shinya
Organization Fukuoka University Faculty of Medicine
Division name Department of Gastroenterology and Medicine
Zip code 8180180
Address 7-45-1, Nanakuma, Jonan-ku, Fukuoka city, Fukuoka
TEL 0928011011
Homepage URL
Email ashizuka@fukuoka-u.ac.jp

Sponsor
Institute Fukuoka University
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Fukuoka University Faculty of Medicine
Address 7-45-1, Nanakuma, Jonan-ku, Fukuoka city, Fukuoka
Tel 0928011011
Email fuhirai@cis.fukuoka-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 07 Month 15 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2022 Year 06 Month 28 Day
Date of IRB
2022 Year 07 Month 11 Day
Anticipated trial start date
2022 Year 08 Month 01 Day
Last follow-up date
2026 Year 03 Month 31 Day
Date of closure to data entry
2026 Year 06 Month 30 Day
Date trial data considered complete
2026 Year 09 Month 30 Day
Date analysis concluded
2027 Year 03 Month 31 Day

Other
Other related information

Management information
Registered date
2022 Year 07 Month 12 Day
Last modified on
2022 Year 07 Month 12 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053953